Description

Bevacizumab Injection is a monoclonal antibody used to treat various cancers, including colorectal, lung, and renal cancers. It inhibits angiogenesis by targeting vascular endothelial growth factor (VEGF), preventing tumor blood supply, slowing tumor growth, and improving overall patient outcomes.